• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Keryx Biopharmaceuticals Inc

+ Add to Watchlist

KERX:US

14.6650 USD 0.5750 4.08%

As of 20:10:00 ET on 12/18/2014.

Company Profile for Keryx Biopharmaceuticals Inc (KERX)

Keryx Biopharmaceuticals, Inc. is focused on developing and commercializing pharmaceuticals for the treatment of renal disease. The Company's product candidate completed Phase 3 testing, pursuant to an SPA agreement with the FDA, for hyperphosphatemia in ESRD patients. The product candidate is also in Phase 2 for non-dialysis dependent CKD patients with iron-deficiency anemia.

Contact Information

Keryx Biopharmaceuticals Inc

750 Lexington Avenue
New York, NY 10022
United States
Phone: 1-212-531-5965
Fax: 1-212-531-5961

Key Executives for Keryx Biopharmaceuticals Inc (KERX)

Ron BentsurChief Executive OfficerJames F OlivieroCFO/Treasurer/Secretary
Gregory P Madison "Greg"Exec VP/COOBrian R AdamsVP/General Counsel
Amy B SullivanVP:Corporate Dev & Public AffairsThomas M EdwardsVP:US Sales
Lauren FischerDirector:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil